<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK333201" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK333201/" /><meta name="ncbi_pagename" content="CHD2-Related Neurodevelopmental Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>CHD2-Related Neurodevelopmental Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="CHD2-Related Neurodevelopmental Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/12/10" /><meta name="citation_author" content="Gemma Carvill" /><meta name="citation_author" content="Ingo Helbig" /><meta name="citation_author" content="Heather Mefford" /><meta name="citation_pmid" content="26677509" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK333201/" /><meta name="citation_keywords" content="CHD2-Related Developmental Delay / Intellectual Disability" /><meta name="citation_keywords" content="CHD2-Related Epileptic Encephalopathy" /><meta name="citation_keywords" content="CHD2-Related Autism Spectrum Disorders" /><meta name="citation_keywords" content="Chromodomain-helicase-DNA-binding protein 2" /><meta name="citation_keywords" content="CHD2" /><meta name="citation_keywords" content="CHD2-Related Neurodevelopmental Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="CHD2-Related Neurodevelopmental Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Gemma Carvill" /><meta name="DC.Contributor" content="Ingo Helbig" /><meta name="DC.Contributor" content="Heather Mefford" /><meta name="DC.Date" content="2015/12/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK333201/" /><meta name="description" content="CHD2-related neurodevelopmental disorders are characterized by early-onset epileptic encephalopathy (i.e., refractory seizures and cognitive slowing or regression associated with frequent ongoing epileptiform activity). Seizure onset is typically between ages six months and four years. Seizure types typically include drop attacks, myoclonus, and a rapid onset of multiple seizure types associated with generalized spike-wave on EEG, atonic-myoclonic-absence seizures, and clinical photosensitivity. Intellectual disability and/or autism spectrum disorders are common. To date only 32 individuals with a CHD2-related neurodevelopmental disorder have been reported; thus, better understanding of the phenotypic spectrum of CHD2-related neurodevelopmental disorders is likely to evolve over time." /><meta name="og:title" content="CHD2-Related Neurodevelopmental Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="CHD2-related neurodevelopmental disorders are characterized by early-onset epileptic encephalopathy (i.e., refractory seizures and cognitive slowing or regression associated with frequent ongoing epileptiform activity). Seizure onset is typically between ages six months and four years. Seizure types typically include drop attacks, myoclonus, and a rapid onset of multiple seizure types associated with generalized spike-wave on EEG, atonic-myoclonic-absence seizures, and clinical photosensitivity. Intellectual disability and/or autism spectrum disorders are common. To date only 32 individuals with a CHD2-related neurodevelopmental disorder have been reported; thus, better understanding of the phenotypic spectrum of CHD2-related neurodevelopmental disorders is likely to evolve over time." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK333201/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/chd2-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK333201/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BD960DFC8D3F100000000038101C2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK333201_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK333201_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/chchd10-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cd-chst3/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK333201_"><span class="title" itemprop="name"><i>CHD2</i>-Related Neurodevelopmental Disorders</span></h1><p class="contrib-group"><span itemprop="author">Gemma Carvill</span>, PhD, <span itemprop="author">Ingo Helbig</span>, MD, and <span itemprop="author">Heather Mefford</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK333201_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK333201_ai__"><div class="contrib half_rhythm"><span itemprop="author">Gemma Carvill</span>, PhD<div class="affiliation small">Department of Pediatrics<br />Division of Genetic Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@llivracg" class="oemail">ude.wu@llivracg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ingo Helbig</span>, MD<div class="affiliation small">Division of Neurology<br />The Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@igibleh" class="oemail">ude.pohc.liame@igibleh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Heather Mefford</span>, MD, PhD<div class="affiliation small">Associate Professor, Department of Pediatrics<br />Division of Genetic Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@droffemh" class="oemail">ude.wu@droffemh</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 10, 2015</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="chd2-dis.Summary" itemprop="description"><h2 id="_chd2-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>CHD2</i>-related neurodevelopmental disorders are characterized by early-onset epileptic encephalopathy (i.e., refractory seizures and cognitive slowing or regression associated with frequent ongoing epileptiform activity). Seizure onset is typically between ages six months and four years. Seizure types typically include drop attacks, myoclonus, and a rapid onset of multiple seizure types associated with generalized spike-wave on EEG, atonic-myoclonic-absence seizures, and clinical photosensitivity. Intellectual disability and/or autism spectrum disorders are common. To date only 32 individuals with a <i>CHD2</i>-related neurodevelopmental disorder have been reported; thus, better understanding of the phenotypic spectrum of <i>CHD2</i>-related neurodevelopmental disorders is likely to evolve over time.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a <i>CHD2</i>-related neurodevelopmental disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>CHD2</i> single-nucleotide <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, small <a class="def" href="/books/n/gene/glossary/def-item/indel/">indel</a> (<a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>) pathogenic variant, or a partial- or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletion detected on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Seizures should be managed by an experienced pediatric neurologist. At this time, no specific guidelines regarding choice of specific antiepileptic drugs (AEDs) exist, as the best AED regimen for <i>CHD2</i>-related neurodevelopmental disorders is not yet established. Most patients remain refractory to treatment and require multiple AEDs.</p><p><i>Agents/circumstances to avoid:</i> Because clinical photosensitivity may result in injuries due to the consequences of induced seizures, it is recommended that stimuli which may provoke seizures (e.g., intensely flickering lights) be avoided.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>CHD2</i>-related neurodevelopmental disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. To date, all <i>CHD2</i>-related neurodevelopmental disorders have resulted from a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., no <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> occurrences are known). However, because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent, the risk of recurrence is presumed to be greater than in the general population. Prenatal testing for pregnancies presumed to be at increased risk is possible.</p></div></div><div id="chd2-dis.GeneReview_Scope"><h2 id="_chd2-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="chd2-dis.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333201/table/chd2-dis.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chd2-dis.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chd2-dis.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHD2</i>-Related Neurodevelopmental Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_chd2-dis.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Developmental delay/intellectual disability</div></li><li class="half_rhythm"><div>Epileptic encephalopathy</div></li><li class="half_rhythm"><div>Autism spectrum disorders</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="chd2-dis.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes, see <a href="#chd2-dis.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="chd2-dis.Diagnosis"><h2 id="_chd2-dis_Diagnosis_">Diagnosis</h2><div id="chd2-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>CHD2</i>-related neurodevelopmental disorders <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div>Early-onset epileptic encephalopathy (i.e., refractory seizures and cognitive slowing or regression associated with frequent ongoing epileptiform activity [<a class="bk_pop" href="#chd2-dis.REF.berg.2010.676">Berg et al 2010</a>]), particularly those with:</div><ul><li class="half_rhythm"><div class="half_rhythm">Seizure onset between ages six months and four years</div></li><li class="half_rhythm"><div class="half_rhythm">Drop attacks and a rapid onset of multiple seizure types associated with generalized spike-wave on EEG</div></li><li class="half_rhythm"><div class="half_rhythm">Atonic-myoclonic-absence seizures (see <a href="#chd2-dis.Clinical_Description">Clinical Description</a>)</div></li><li class="half_rhythm"><div class="half_rhythm">Clinical photosensitivity</div><div class="half_rhythm">Note: Photic stimulation during an EEG may be a helpful diagnostic modality even though not all individuals with a <i>CHD2</i>-related neurodevelopmental disorder and clinical photosensitivity show an EEG response to photic stimulation. Nonetheless, the possible increased risk for photic-induced seizures in individuals with this disorder should be taken into account when obtaining an EEG with photic stimulation.</div></li></ul></li><li class="half_rhythm"><div>Intellectual disability and/or autism spectrum disorders, particularly when epilepsy is also present</div></li></ul></div><div id="chd2-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The <b>diagnosis of a <i>CHD2</i>-related neurodevelopmental disorder</b>
<b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>CHD2</i> single-nucleotide <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, small <a class="def" href="/books/n/gene/glossary/def-item/indel/">indel</a> (<a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>) pathogenic variant (<a class="figpopup" href="/books/NBK333201/figure/chd2-dis.F1/?report=objectonly" target="object" rid-figpopup="figchd2disF1" rid-ob="figobchd2disF1">Figure 1</a>) or a partial- or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletion detected on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (<a class="figpopup" href="/books/NBK333201/table/chd2-dis.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figchd2disTmoleculargenetictestinguse" rid-ob="figobchd2disTmoleculargenetictestinguse">Table 1</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figchd2disF1" co-legend-rid="figlgndchd2disF1"><a href="/books/NBK333201/figure/chd2-dis.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figchd2disF1" rid-ob="figobchd2disF1"><img class="small-thumb" src="/books/NBK333201/bin/chd2-dis-Image001.gif" src-large="/books/NBK333201/bin/chd2-dis-Image001.jpg" alt="Figure 1. . Distribution of single-nucleotide and small indel pathogenic variants in CHD2 in individuals with epileptic encephalopathy (top panel) and intellectual disability (ID) and autism spectrum disorder (ASD) (bottom panel)." /></a><div class="icnblk_cntnt" id="figlgndchd2disF1"><h4 id="chd2-dis.F1"><a href="/books/NBK333201/figure/chd2-dis.F1/?report=objectonly" target="object" rid-ob="figobchd2disF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Distribution of single-nucleotide and small indel pathogenic variants in CHD2 in individuals with epileptic encephalopathy (top panel) and intellectual disability (ID) and autism spectrum disorder (ASD) (bottom panel). Vertical lines show the position <a href="/books/NBK333201/figure/chd2-dis.F1/?report=objectonly" target="object" rid-ob="figobchd2disF1">(more...)</a></p></div></div><p>Molecular genetic testing approaches can include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, <b><a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> microarray analysis (CMA)</b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CHD2</i> and other genes of interest (see <a href="#chd2-dis.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Chromosome microarray analysis (CMA)</b> &#x02013; if not already performed as part of the diagnostic work up &#x02013; may be performed to detect genome-wide deletions/duplications (including <i>CHD2</i>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>CHD2</i>) fails to confirm a diagnosis in an individual with features of <i>CHD2</i>-related neurodevelopmental disorders. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="chd2-dis.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>CHD2</i>-Related Neurodevelopmental Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333201/table/chd2-dis.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chd2-dis.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a <i>CHD2</i> Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHD2</i></td><td headers="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24/32 (75%)</td></tr><tr><td headers="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup> (<a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> approach)</td><td headers="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8/32 (25%)&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_chd2-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="chd2-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK333201/#chd2-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="chd2-dis.TF.1.2"><p class="no_margin">See <a href="#chd2-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="chd2-dis.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="chd2-dis.TF.1.4"><p class="no_margin">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis (<a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> approach) detects <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 15q26 using a <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="chd2-dis.TF.1.5"><p class="no_margin">Individuals with features of <i>CHD2-</i>related disorders who have deletions encompassing <i>CHD2</i> (with or without <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>RGMA)</i> have been reported [<a class="bk_pop" href="#chd2-dis.REF.dhamija.2011.60">Dhamija et al 2011</a>, <a class="bk_pop" href="#chd2-dis.REF.capelli.2012.132">Capelli et al 2012</a>, <a class="bk_pop" href="#chd2-dis.REF.ch_nier.2014.9">Ch&#x000e9;nier et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.courage.2014.520">Courage et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.pinto.2014.677">Pinto et al 2014</a>].</p></div></dd><dt>6. </dt><dd><div id="chd2-dis.TF.1.6"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>7. </dt><dd><div id="chd2-dis.TF.1.7"><p class="no_margin">No intragenic <i>CHD2</i> multiexon deletions or duplications have been reported.</p></div></dd></dl></div></div></div></div></div><div id="chd2-dis.Clinical_Characteristics"><h2 id="_chd2-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="chd2-dis.Clinical_Description"><h3>Clinical Description</h3><p>To date 32 individuals with a <i>CHD2</i>-related neurodevelopmental disorder have been reported [<a class="bk_pop" href="#chd2-dis.REF.capelli.2012.132">Capelli et al 2012</a>, <a class="bk_pop" href="#chd2-dis.REF.neale.2012.242">Neale et al 2012</a>, <a class="bk_pop" href="#chd2-dis.REF.rauch.2012.1674">Rauch et al 2012</a>, <a class="bk_pop" href="#chd2-dis.REF.lund.2013.110">Lund et al 2013</a>, <a class="bk_pop" href="#chd2-dis.REF.ch_nier.2014.9">Ch&#x000e9;nier et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.hamdan.2014.e1004772">Hamdan et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.lund.2014.18">Lund et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.oroak.2014.5595">O'Roak et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.pinto.2014.677">Pinto et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.deciphering_developmental_disorders_study_group.2015.223">Deciphering Developmental Disorders Study Group 2015</a>, <a class="bk_pop" href="#chd2-dis.REF.trivisano.2015.53">Trivisano et al 2015</a>].</p><p>Detailed clinical information is available for 16 of the 32 [<a class="bk_pop" href="#chd2-dis.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#chd2-dis.REF.suls.2013.967">Suls et al 2013</a>, <a class="bk_pop" href="#chd2-dis.REF.lund.2014.18">Lund et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.thomas.2015.951">Thomas et al 2015</a>, <a class="bk_pop" href="#chd2-dis.REF.trivisano.2015.53">Trivisano et al 2015</a>]. While epilepsy is a consistent feature across the phenotypic spectrum of <i>CHD2</i>-related neurodevelopmental disorders, it is likely that better understanding of the phenotypic spectrum will evolve as more <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are identified.</p><p>The most common clinical features of these individuals are described below.</p><p><b>Seizures.</b> The age of onset ranges from six months to four years.</p><p>Seizure onset, which is explosive in many children, is characterized by multiple, daily myoclonic and absence seizures.</p><p>Febrile seizures are rarely the first seizure type observed (4/16 children) [<a class="bk_pop" href="#chd2-dis.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#chd2-dis.REF.suls.2013.967">Suls et al 2013</a>, <a class="bk_pop" href="#chd2-dis.REF.lund.2014.18">Lund et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.thomas.2015.951">Thomas et al 2015</a>, <a class="bk_pop" href="#chd2-dis.REF.trivisano.2015.53">Trivisano et al 2015</a>].</p><p>A classic seizure type termed "atonic-myoclonic-absence seizure," a progressive seizure pattern comprising an abrupt head nod and atonia followed by a myoclonic absence phase and progression to a "ratchet-like" tonic abduction of the upper limbs, was observed in video footage of three children aged two to seven years. Seizures were brief (2-8 seconds) and awareness rapidly returned [<a class="bk_pop" href="#chd2-dis.REF.thomas.2015.951">Thomas et al 2015</a>]. Many of the components of this seizure pattern have been described in other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; thus, future video monitoring and video-EEG monitoring will be important in determining if this seizure pattern is a hallmark of <i>CHD2</i>-related neurodevelopmental disorders.</p><p>Clinical photosensitivity (i.e., seizures triggered by photic stimulation) is a distinguishing feature reported in nine of 12 individuals. Seven of the nine could self-induce seizures, suggesting an unusually strong degree of photosensitivity. In contrast, a photoparoxysmal response (an epileptiform EEG response to intermittent photic stimulation) has only been recorded in two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#chd2-dis.REF.lund.2014.18">Lund et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.thomas.2015.951">Thomas et al 2015</a>, <a class="bk_pop" href="#chd2-dis.REF.trivisano.2015.53">Trivisano et al 2015</a>]. Of note, some individuals with a <i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a diagnosis of eyelid myoclonia with absences (EMA), a particularly photosensitive epilepsy syndrome [<a class="bk_pop" href="#chd2-dis.REF.galizia.2015.1198">Galizia et al 2015</a>].</p><p>Seizures are generally refractory to currently available antiepileptic drugs (AEDs). Only four of 16 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been reported to be seizure free on AED treatment for two to five years (see <a href="#chd2-dis.Management">Management</a>).</p><p><b>Psychomotor development</b> prior to seizure onset is frequently delayed (11/16 children). When specifically reported in the literature, intellectual disability ranges from mild (7/15) to severe (8/15).</p><p><b>Behavior phenotypes</b>. Autism spectrum disorder (ASD) or autistic features have been reported in six of 15 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Challenging behaviors, most often aggression, were described in eight of 11 individuals, with three requiring medical treatment with risperidone. It is currently unclear to what extent a specific behavior <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is part of the phenotypic spectrum.</p><p><b>Neuroimaging.</b> In some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals MRI has shown atrophy that tends to be more posterior and can be progressive. In those with ataxia, cerebellar atrophy was more pronounced [<a class="bk_pop" href="#chd2-dis.REF.suls.2013.967">Suls et al 2013</a>, <a class="bk_pop" href="#chd2-dis.REF.thomas.2015.951">Thomas et al 2015</a>].</p></div><div id="chd2-dis.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation has been observed between the location/nature of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and clinical outcome (<a class="figpopup" href="/books/NBK333201/figure/chd2-dis.F1/?report=objectonly" target="object" rid-figpopup="figchd2disF1" rid-ob="figobchd2disF1">Figure 1</a>); however, the number of reported individuals with a <i>CHD2</i>-related neurodevelopmental disorder is still relatively small and patterns may emerge as more <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are identified.</p><p>A cluster of truncating pathogenic variants in the C terminus has been reported in individuals with epileptic encephalopathy, intellectual disability (ID), and/or autism spectrum disorders (ASD). Of note, the same recurrent <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="figpopup" href="/books/NBK333201/table/chd2-dis.T.chd2_pathogenic_variants_disc/?report=objectonly" target="object" rid-figpopup="figchd2disTchd2pathogenicvariantsdisc" rid-ob="figobchd2disTchd2pathogenicvariantsdisc">p.Arg1637Ter</a>, has been identified in an individual with ASD without seizures and in an individual with ID and a seizure disorder described as "genetic generalized epilepsy" [<a class="bk_pop" href="#chd2-dis.REF.oroak.2014.5595">O'Roak et al 2014</a>; Carvill, unpublished], suggesting phenotypic variability even in individuals with the same pathogenic variant.</p></div><div id="chd2-dis.Penetrance"><h3>Penetrance</h3><p>Penetrance for <i>CHD2</i>-related neurodevelopmental disorders is unknown but assumed to be complete.</p></div><div id="chd2-dis.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>CHD2-</i>related neurodevelopmental disorders is not known.</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was present in an estimated 1% of individuals included in cohorts with various epileptic encephalopathies [<a class="bk_pop" href="#chd2-dis.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#chd2-dis.REF.carvill.2013.825">Carvill et al 2013</a>].</p><p>In each of four studies of <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a>-based sequencing of hundreds to thousands of individuals with neurodevelopmental disorders including intellectual disability and autism spectrum disorders, one to three individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were identified [<a class="bk_pop" href="#chd2-dis.REF.neale.2012.242">Neale et al 2012</a>, <a class="bk_pop" href="#chd2-dis.REF.rauch.2012.1674">Rauch et al 2012</a>, <a class="bk_pop" href="#chd2-dis.REF.oroak.2014.5595">O'Roak et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.deciphering_developmental_disorders_study_group.2015.223">Deciphering Developmental Disorders Study Group 2015</a>].</p></div></div><div id="chd2-dis.Genetically_Related_Allelic_Dis"><h2 id="_chd2-dis_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>CHD2</i>.</p></div><div id="chd2-dis.Differential_Diagnosis"><h2 id="_chd2-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Myoclonic absence epilepsy (MAE)</b> (also known as Doose syndrome) was the original diagnosis in three of six individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#chd2-dis.REF.carvill.2013.825">Carvill et al 2013</a>]. In contrast to individuals with MAE, patients with a <i>CHD2</i>-related neurodevelopmental disorder generally have delayed development prior to seizure onset and often have clinical photosensitivity. Tonic seizures are also more frequently seen in children with <i>CHD2</i> pathogenic variants. Although the etiology is unknown in the majority of individuals with MAE, a <i>de novo</i> pathogenic variant in <i>SLC2A1</i> or <i>SLC6A1</i> was found in up to 10% of individuals in some case series [<a class="bk_pop" href="#chd2-dis.REF.mullen.2011.1152">Mullen et al 2011</a>, <a class="bk_pop" href="#chd2-dis.REF.carvill.2015.808">Carvill et al 2015</a>].</p><p><b>Lennox Gastaut syndrome (LGS)</b> was the original diagnosis in three individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. LGS is an epileptic encephalopathy characterized by multiple types of seizures that are typically refractory to treatment, moderate to severe intellectual disability, and a slow spike and wave pattern on EEG. The genetic causes are heterogeneous: <i>de novo</i> pathogenic variants have been identified in numerous genes including <i>STXBP1, CDKL5, GABRB3, SCN1A,</i> and <i>SCN2A</i> [<a class="bk_pop" href="#chd2-dis.REF.allen.2013.217">Allen et al 2013</a>]. See <a href="/books/n/gene/stxbp1-ee/"><i>STXBP1</i> Encephalopathy with Epilepsy</a>.</p><p><a href="/books/n/gene/gefs/"><b>Dravet syndrome</b></a><b>,</b> an infantile epileptic encephalopathy with onset before age 15 months, is characterized by hemiclonic or generalized seizures that are often triggered and prolonged by fever. Additional seizure types develop over time and psychomotor regression and intellectual disability are common. Over 75% of individuals with Dravet syndrome have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SCN1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#chd2-dis.REF.marini.2011.24">Marini et al 2011</a>]. In contrast to the seizures of Dravet syndrome, the seizures of <i>CHD2</i>-related neurodevelopmental disorders are not commonly triggered by fever (4/15 cases) [<a class="bk_pop" href="#chd2-dis.REF.suls.2013.967">Suls et al 2013</a>, <a class="bk_pop" href="#chd2-dis.REF.thomas.2015.951">Thomas et al 2015</a>, <a class="bk_pop" href="#chd2-dis.REF.trivisano.2015.53">Trivisano et al 2015</a>].</p><p><b>Intellectual disability</b>
<b>with epilepsy.</b> A total of four individuals with nonsyndromic intellectual disability and a <i>de novo CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been identified by large <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> studies. Three of the four also had epilepsy [<a class="bk_pop" href="#chd2-dis.REF.rauch.2012.1674">Rauch et al 2012</a>, <a class="bk_pop" href="#chd2-dis.REF.hamdan.2014.e1004772">Hamdan et al 2014</a>, <a class="bk_pop" href="#chd2-dis.REF.deciphering_developmental_disorders_study_group.2015.223">Deciphering Developmental Disorders Study Group 2015</a>].</p><p><b>Autism spectrum disorder (ASD).</b> A <i>de novo CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in four individuals in a targeted study of approximately 3500 individuals with ASD and in one individual in an <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> study of 175 individuals. All five had ASD and intellectual disability; three also had epilepsy [<a class="bk_pop" href="#chd2-dis.REF.neale.2012.242">Neale et al 2012</a>, <a class="bk_pop" href="#chd2-dis.REF.oroak.2014.5595">O'Roak et al 2014</a>].</p></div><div id="chd2-dis.Management"><h2 id="_chd2-dis_Management_">Management</h2><div id="chd2-dis.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>CHD2</i>-related neurodevelopmental disorder, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic examination including:</div><ul><li class="half_rhythm"><div>EEG, which may provide an assessment of the overall degree of epileptic encephalopathy and may lead to more focused use of antiepileptic drugs (AEDs);</div></li><li class="half_rhythm"><div>MRI, which is initially important to differentiate the genetic epilepsy from a lesional epilepsy and may lead to intensified conservative treatment rather than presurgical work up.</div></li></ul></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Clinical genetics and/or child neurology consultation</div></li></ul></div><div id="chd2-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Seizures should be managed by an experienced pediatric neurologist.</p><p>At this time, no specific guidelines regarding choice of specific antiepileptic drugs (AEDs) exist, as the best AED regimen for <i>CHD2</i>-related neurodevelopmental disorders is not yet established. Most patients remain refractory to treatment and require multiple AEDs.</p><p>Although a ketogenic diet may be a treatment option, it was not effective in three patients [<a class="bk_pop" href="#chd2-dis.REF.thomas.2015.951">Thomas et al 2015</a>].</p><p>For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p></div><div id="chd2-dis.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Because clinical photosensitivity may result in injuries due to the consequences of induced seizures, the following are recommended:</p><ul><li class="half_rhythm"><div>Avoid flickering lights that may provoke seizures.</div></li><li class="half_rhythm"><div>Advise patients and families that exposure to intensely flickering lights may provoke seizures including eyelid myoclonias, absence seizures, and generalized tonic-clonic seizures. Of note, most televisions do not transmit in the frequency range that is particularly provocative.</div></li></ul></div><div id="chd2-dis.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#chd2-dis.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="chd2-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="chd2-dis.Genetic_Counseling"><h2 id="_chd2-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="chd2-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>CHD2</i>-related neurodevelopmental disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. To date, all <i>CHD2</i>-related neurodevelopmental disorders have resulted from a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., no <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> occurrences are known).</p></div><div id="chd2-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date, all individuals diagnosed with <i>CHD2</i>-related neurodevelopmental disorders have been <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>When the <i>CHD2</i> variant found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, the proband most likely has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in a parent is also possible although no instances of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported to date.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>To date, all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have had a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> suggesting a low risk to sibs. However, because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent, the risk is presumed to be greater than in the general population.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with a <i>CHD2</i>-related neurodevelopmental disorder has a 50% chance of inheriting the <i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>To date, individuals with a <i>CHD2</i>-related neurodevelopmental disorder are not known to reproduce; however, many are still children.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents. To date, no parents have been <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="chd2-dis.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="chd2-dis.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for a <i>CHD2</i>-related neurodevelopmental disorder are possible.</p></div></div><div id="chd2-dis.Resources"><h2 id="_chd2-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Autism Society of America</b></div><div><i>Publishes the "Advocate," an informative quarterly magazine</i></div><div>4340 East-West Highway</div><div>Suite 350</div><div>Betheseda MD 20814</div><div><b>Phone:</b> 800-328-8476 (toll-free); 301-657-0881</div><div><a href="http://www.autism-society.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.autism-society.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Citizens United for Research in Epilepsy (CURE)</b></div><div><a href="http://www.cureepilepsy.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cureepilepsy.org</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>Simons VIP Connect Registry</b></div><div><i>An online community for individuals with genetic causes of autism. Simons VIP Connect is currently recruiting for a research study aimed to better understand the medical, cognitive and behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of individuals with certain CNV's and genes related to autism.An online community for individuals with genetic causes of autism. Simons VIP Connect is currently recruiting for a research study aimed to better understand the medical, cognitive and behavioral phenotype of individuals with certain CNV's and genes related to autism.</i></div><div><a href="http://www.simonsvipconnect.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Simons VIP Connect</a></div></li></ul></div><div id="chd2-dis.Molecular_Genetics"><h2 id="_chd2-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="chd2-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>CHD2-Related Neurodevelopmental Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333201/table/chd2-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chd2-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_chd2-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_chd2-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_chd2-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_chd2-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_chd2-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_chd2-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1106" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHD2</i></a></td><td headers="hd_b_chd2-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1106" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q26<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_chd2-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O14647" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Chromodomain-helicase-DNA-binding protein 2</a></td><td headers="hd_b_chd2-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHD2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHD2</a></td><td headers="hd_b_chd2-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHD2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHD2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="chd2-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="chd2-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for CHD2-Related Neurodevelopmental Disorders (<a href="/omim/602119,615369" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333201/table/chd2-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chd2-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602119" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602119</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 2; CHD2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615369" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615369</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC</td></tr></tbody></table></div></div><div id="chd2-dis.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p><i>CHD2</i> encodes the chromodomain DNA helicase binding protein 2. CHD2 and additional members of this family of proteins are responsible for remodeling chromatin, which controls the three-dimensional architecture of the genome and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression.</p><p>The function of CHD2 in the human brain is not known; in mice, the ortholog Chd2 binds the <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> MyoD in muscle and promotes the expression of genes that promote myogenesis [<a class="bk_pop" href="#chd2-dis.REF.harada.2012.2994">Harada et al 2012</a>]. Moreover, when Chd2 was depleted from mouse neuronal progenitor cells, the pool of progenitor cells was reduced, and cells differentiated prematurely into other neural lineages [<a class="bk_pop" href="#chd2-dis.REF.shen.2015.1794">Shen et al 2015</a>]. Human CHD2 may have a similar function in the brain and control neuronal development and/or functioning.</p><p>The overwhelming majority of <i>CHD2</i> pathogenic variants lead to either truncation of the protein or loss of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression by whole-gene <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, suggesting that <i>CHD2-</i>related neurodevelopmental disorders result from CHD2 <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. Mouse and zebrafish models exhibit global abnormalities; however, only zebrafish knockdowns had a neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> indicative of seizures [<a class="bk_pop" href="#chd2-dis.REF.marfella.2006.162">Marfella et al 2006</a>, <a class="bk_pop" href="#chd2-dis.REF.marfella.2008.421">Marfella et al 2008</a>, <a class="bk_pop" href="#chd2-dis.REF.suls.2013.967">Suls et al 2013</a>]. In contrast to these model systems, to date the majority of individuals with a <i>CHD2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a brain-restricted phenotype, suggesting a unique role for CHD2 in the human brain.</p><p><b>Gene structure.</b> The longest <i>CHD2</i> transcript variant (<a href="/nuccore/?term=NM_001271.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001271.3</a>) consists of 39 exons and a processed <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> transcript of 9374 bp sequence. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK333201/#chd2-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of pathogenic variants result in protein truncation or whole- or partial-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions; only four <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants in the highly conserved helicase domains have been described.</p><div id="chd2-dis.T.chd2_pathogenic_variants_disc" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>CHD2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333201/table/chd2-dis.T.chd2_pathogenic_variants_disc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chd2-dis.T.chd2_pathogenic_variants_disc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.335C&#x0003e;G</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser112Ter</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_3" rowspan="23" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/?term=NM_001271.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001271<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_001262.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001262<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.361C&#x0003e;T</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg121Ter</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1396C&#x0003e;T</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg466Ter</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1450_1451insT</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg485SerfsTer19</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1502+1G&#x0003e;A</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1642T&#x0003e;C</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp548Arg</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1808delA</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr604LeufsTer19</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1942C&#x0003e;T</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro648Ser</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2468T&#x0003e;C</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu823Pro</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2567A&#x0003e;G</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp856Gly</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2725C&#x0003e;T</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln909Ter</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not given</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu966SerfsTer2</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4233_4236delAGAA</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu1412GlyfsTer64</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4256_4274del19</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys1419fsTer1421</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4720delG</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1575ValfsTer17</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4173dupA</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln1392ThrfsTer17</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not given</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu1591Terfs</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not given</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn1600SerfsTer209</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4909C&#x0003e;T</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1637Ter</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not given</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln1641Ter</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4930_4931delAG</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1644LysfsTer22</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not given</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1651TrpfsTer16</td></tr><tr><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4971G&#x0003e;A</td><td headers="hd_h_chd2-dis.T.chd2_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp1657Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gene is ubiquitously expressed in mouse and human [<a class="bk_pop" href="#chd2-dis.REF.marfella.2006.162">Marfella et al 2006</a>]. CHD2 comprises 1828 amino acids and encodes a DNA-binding chromatin remodeler (<a class="figpopup" href="/books/NBK333201/figure/chd2-dis.F1/?report=objectonly" target="object" rid-figpopup="figchd2disF1" rid-ob="figobchd2disF1">Figure 1</a>). The protein consists of two chromodomains and a putative DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>; these domains are known or hypothesized to bind DNA [<a class="bk_pop" href="#chd2-dis.REF.marfella.2007.30">Marfella &#x00026; Imbalzano 2007</a>, <a class="bk_pop" href="#chd2-dis.REF.liu.2015.25">Liu et al 2015</a>]. The ATP-helicase and DEDX-helicase domain are known in other family members to remodel chromatin using the energy of ATP hydrolysis [<a class="bk_pop" href="#chd2-dis.REF.marfella.2007.30">Marfella &#x00026; Imbalzano 2007</a>, <a class="bk_pop" href="#chd2-dis.REF.bouazoune.2012.19238">Bouazoune &#x00026; Kingston 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The majority of pathogenic variants lead to truncation of <i>CHD2</i>. The few reported <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants (<a class="figpopup" href="/books/NBK333201/figure/chd2-dis.F1/?report=objectonly" target="object" rid-figpopup="figchd2disF1" rid-ob="figobchd2disF1">Figure 1</a>) occur in the highly conserved helicase domains and likely hinder the ability of CHD2 to remodel chromatin. <i>CHD2</i> pathogenic variants are likely all <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a>, resulting in <i>CHD2</i>-related neurodevelopmental disorders due to <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of CHD2.</p></div></div><div id="chd2-dis.References"><h2 id="_chd2-dis_References_">References</h2><div id="chd2-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.allen.2013.217">Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, McGuire SM, Motika PV, Novotny EJ, Paolicchi JM, Parent JM, Park K, Shellhaas RA, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. De novo mutations in epileptic encephalopathies. <span><span class="ref-journal">Nature. </span>2013;<span class="ref-vol">501</span>:217–21.</span> [<a href="/pmc/articles/PMC3773011/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3773011</span></a>] [<a href="/pubmed/23934111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23934111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.berg.2010.676">Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Mosh&#x000e9; SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:676–85.</span> [<a href="/pubmed/20196795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20196795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.bouazoune.2012.19238">Bouazoune K, Kingston RE. Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2012;<span class="ref-vol">109</span>:19238–43.</span> [<a href="/pmc/articles/PMC3511097/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3511097</span></a>] [<a href="/pubmed/23134727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23134727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.capelli.2012.132">Capelli LP, Krepischi AC, Gurgel-Giannetti J, Mendes MF, Rodrigues T, Varela MC, Koiffmann CP, Rosenberg C. Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:132–4.</span> [<a href="/pubmed/22178256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22178256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.carvill.2013.825">Carvill GL, Heavin SB, Yendle SC, McMahon JM, O'Roak BJ, Cook J, Khan A, Dorschner MO, Weaver M, Calvert S, Malone S, Wallace G, Stanley T, Bye AM, Bleasel A, Howell KB, Kivity S, Mackay MT, Rodriguez-Casero V, Webster R, Korczyn A, Afawi Z, Zelnick N, Lerman-Sagie T, Lev D, Moller RS, Gill D, Andrade DM, Freeman JL, Sadleir LG, Shendure J, Berkovic SF, Scheffer IE, Mefford HC. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:825–30.</span> [<a href="/pmc/articles/PMC3704157/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3704157</span></a>] [<a href="/pubmed/23708187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23708187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.carvill.2015.808">Carvill GL, McMahon JM, Schneider A, Zemel M, Myers CT, Saykally J, Nguyen J, Robbiano A, Zara F, Specchio N, Mecarelli O, Smith RL, Leventer RJ, M&#x000f8;ller RS, Nikanorova M, Dimova P, Jordanova A, Petrou S, Helbig I, Striano P, Weckhuysen S, Berkovic SF, Scheffer IE, Mefford HC, et al.  Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">96</span>:808–15.</span> [<a href="/pmc/articles/PMC4570550/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4570550</span></a>] [<a href="/pubmed/25865495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25865495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.ch_nier.2014.9">Ch&#x000e9;nier S, Yoon G, Argiropoulos B, Lauzon J, Laframboise R, Ahn JW, Ogilvie CM, Lionel AC, Marshall CR, Vaags AK, Hashemi B, Boisvert K, Mathonnet G, Tihy F, So J, Scherer SW, Lemyre E, Stavropoulos DJ. CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems. <span><span class="ref-journal">J Neurodev Disord. </span>2014;<span class="ref-vol">6</span>:9.</span> [<a href="/pmc/articles/PMC4022362/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4022362</span></a>] [<a href="/pubmed/24834135" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24834135</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.courage.2014.520">Courage C, Houge G, Gallati S, Schjelderup J, Rieubland C. 15q26.1 microdeletion encompassing only CHD2 and RGMA in two adults with moderate intellectual disability, epilepsy and truncal obesity. <span><span class="ref-journal">Eur J Med Genet. </span>2014;<span class="ref-vol">57</span>:520–3.</span> [<a href="/pubmed/24932903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24932903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.deciphering_developmental_disorders_study_group.2015.223">Deciphering Developmental Disorders Study Group.  Large-scale discovery of novel genetic causes of developmental disorders. <span><span class="ref-journal">Nature. </span>2015;<span class="ref-vol">519</span>:223–8.</span> [<a href="/pmc/articles/PMC5955210/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5955210</span></a>] [<a href="/pubmed/25533962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25533962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.dhamija.2011.60">Dhamija R, Breningstall G, Wong-Kisiel L, Dolan M, Hirsch B, Wirrell E. Microdeletion of chromosome 15q26.1 in a child with intractable generalized epilepsy. <span><span class="ref-journal">Pediatr Neurol. </span>2011;<span class="ref-vol">45</span>:60–2.</span> [<a href="/pubmed/21723464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21723464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.galizia.2015.1198">Galizia EC, Myers CT, Leu C, de Kovel CGF, Afrikanova T, Cordero-Maldonado ML, Martins TG, Jacmin M, Drury S, Chinthapalli VK, Muhle H, Pendziwiat M, Sander T, Ruppert A-K, Moller RS, Thiele H, Krause R, Schubert J, Lehesjoki A-E, Nurnberg P, Lerche H, Palotie A, Coppola A, Striano S, Del Gaudio L, Boustred C, Schneider AL, Lench N, Jocic-Jakubi B, Covanis A, Capovilla G, Veggotti P, Piccioli M, Parisi P, Cantonetti L, Sadleir LG, Mullen SA, Berkovic SF, Stephani U, Helbig I, Crawford AD, Esguerra CV, Kasteleijn-Nolst Trenite DGA, Koeleman BPC, Mefford HC, Scheffer IE, Sisodiya SM. CHD2 variants are a risk factor for photosensitivity in epilepsy. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:1198–207.</span> [<a href="/pmc/articles/PMC4407192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4407192</span></a>] [<a href="/pubmed/25783594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25783594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.hamdan.2014.e1004772">Hamdan FF, Srour M, Capo-Chichi JM, Daoud H, Nassif C, Patry L, Massicotte C, Ambalavanan A, Spiegelman D, Diallo O, Henrion E, Dionne-Laporte A, Fougerat A, Pshezhetsky AV, Venkateswaran S, Rouleau GA, Michaud JL. De novo mutations in moderate or severe intellectual disability. <span><span class="ref-journal">PLoS Genet. </span>2014;<span class="ref-vol">10</span>:e1004772.</span> [<a href="/pmc/articles/PMC4214635/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4214635</span></a>] [<a href="/pubmed/25356899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25356899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.harada.2012.2994">Harada A, Okada S, Konno D, Odawara J, Yoshimi T, Yoshimura S, Kumamaru H, Saiwai H, Tsubota T, Kurumizaka H, Akashi K, Tachibana T, Imbalzano AN, Ohkawa Y. Chd2 interacts with H3.3 to determine myogenic cell fate. <span><span class="ref-journal">Embo J. </span>2012;<span class="ref-vol">31</span>:2994–3007.</span> [<a href="/pmc/articles/PMC3395093/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3395093</span></a>] [<a href="/pubmed/22569126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22569126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.liu.2015.25">Liu JC, Ferreira CG, Yusufzai T. Human CHD2 Is a chromatin assembly ATPase regulated by its chromo- and DNA-binding domains. <span><span class="ref-journal">J Biol Chem. </span>2015;<span class="ref-vol">290</span>:25–34.</span> [<a href="/pmc/articles/PMC4281729/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4281729</span></a>] [<a href="/pubmed/25384982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25384982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.lund.2014.18">Lund C, Brodtkorb E, Oye AM, Rosby O, Selmer KK. CHD2 mutations in Lennox-Gastaut syndrome. <span><span class="ref-journal">Epilepsy Behav. </span>2014;<span class="ref-vol">33</span>:18–21.</span> [<a href="/pubmed/24614520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24614520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.lund.2013.110">Lund C, Brodtkorb E, Rosby O, Rodningen OK, Selmer KK. Copy number variants in adult patients with Lennox-Gastaut syndrome features. <span><span class="ref-journal">Epilepsy Res. </span>2013;<span class="ref-vol">105</span>:110–7.</span> [<a href="/pubmed/23415449" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23415449</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.marfella.2007.30">Marfella CG, Imbalzano AN. The Chd family of chromatin remodelers. <span><span class="ref-journal">Mutat Res. </span>2007;<span class="ref-vol">618</span>:30–40.</span> [<a href="/pmc/articles/PMC1899158/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1899158</span></a>] [<a href="/pubmed/17350655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17350655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.marfella.2008.421">Marfella CG, Henninger N, LeBlanc SE, Krishnan N, Garlick DS, Holzman LB, Imbalzano AN. A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex. <span><span class="ref-journal">Kidney Blood Press Res. </span>2008;<span class="ref-vol">31</span>:421–32.</span> [<a href="/pmc/articles/PMC2818461/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2818461</span></a>] [<a href="/pubmed/19142019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19142019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.marfella.2006.162">Marfella CG, Ohkawa Y, Coles AH, Garlick DS, Jones SN, Imbalzano AN. Mutation of the SNF2 family member Chd2 affects mouse development and survival. <span><span class="ref-journal">J Cell Physiol. </span>2006;<span class="ref-vol">209</span>:162–71.</span> [<a href="/pubmed/16810678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16810678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.marini.2011.24">Marini C, Scheffer IE, Nabbout R, Suls A, De Jonghe P, Zara F, Guerrini R. The genetics of Dravet syndrome. <span><span class="ref-journal">Epilepsia. </span>2011;<span class="ref-vol">52</span>:24–9.</span> [<a href="/pubmed/21463275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21463275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.mullen.2011.1152">Mullen SA, Marini C, Suls A, Mei D, Della Giustina E, Buti D, Arsov T, Damiano J, Lawrence K, De Jonghe P, Berkovic SF, Scheffer IE, Guerrini R. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. <span><span class="ref-journal">Arch Neurol. </span>2011;<span class="ref-vol">68</span>:1152–5.</span> [<a href="/pubmed/21555602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21555602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.neale.2012.242">Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin CF, Stevens C, Wang LS, Makarov V, Polak P, Yoon S, Maguire J, Crawford EL, Campbell NG, Geller ET, Valladares O, Schafer C, Liu H, Zhao T, Cai G, Lihm J, Dannenfelser R, Jabado O, Peralta Z, Nagaswamy U, Muzny D, Reid JG, Newsham I, Wu Y, Lewis L, Han Y, Voight BF, Lim E, Rossin E, Kirby A, Flannick J, Fromer M, Shakir K, Fennell T, Garimella K, Banks E, Poplin R, Gabriel S, DePristo M, Wimbish JR, Boone BE, Levy SE, Betancur C, Sunyaev S, Boerwinkle E, Buxbaum JD, Cook EH Jr, Devlin B, Gibbs RA, Roeder K, Schellenberg GD, Sutcliffe JS, Daly MJ. Patterns and rates of exonic de novo mutations in autism spectrum disorders. <span><span class="ref-journal">Nature. </span>2012;<span class="ref-vol">485</span>:242–5.</span> [<a href="/pmc/articles/PMC3613847/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3613847</span></a>] [<a href="/pubmed/22495311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22495311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.oroak.2014.5595">O'Roak BJ, Stessman HA, Boyle EA, Witherspoon KT, Martin B, Lee C, Vives L, Baker C, Hiatt JB, Nickerson DA, Bernier R, Shendure J, Eichler EE. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. <span><span class="ref-journal">Nat Commun. </span>2014;<span class="ref-vol">5</span>:5595.</span> [<a href="/pmc/articles/PMC4249945/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4249945</span></a>] [<a href="/pubmed/25418537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25418537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.pinto.2014.677">Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, Thiruvahindrapuram B, Xu X, Ziman R, Wang Z, Vorstman JA, Thompson A, Regan R, Pilorge M, Pellecchia G, Pagnamenta AT, Oliveira B, Marshall CR, Magalhaes TR, Lowe JK, Howe JL, Griswold AJ, Gilbert J, Duketis E, Dombroski BA, De Jonge MV, Cuccaro M, Crawford EL, Correia CT, Conroy J, Concei&#x000e7;&#x000e3;o IC, Chiocchetti AG, Casey JP, Cai G, Cabrol C, Bolshakova N, Bacchelli E, Anney R, Gallinger S, Cotterchio M, Casey G, Zwaigenbaum L, Wittemeyer K, Wing K, Wallace S, van Engeland H, Tryfon A, Thomson S, Soorya L, Rog&#x000e9; B, Roberts W, Poustka F, Mouga S, Minshew N, McInnes LA, McGrew SG, Lord C, Leboyer M, Le Couteur AS, Kolevzon A, Jim&#x000e9;nez Gonz&#x000e1;lez P, Jacob S, Holt R, Guter S, Green J, Green A, Gillberg C, Fernandez BA, Duque F, Delorme R, Dawson G, Chaste P, Caf&#x000e9; C, Brennan S, Bourgeron T, Bolton PF, B&#x000f6;lte S, Bernier R, Baird G, Bailey AJ, Anagnostou E, Almeida J, Wijsman EM, Vieland VJ, Vicente AM, Schellenberg GD, Pericak-Vance M, Paterson AD, Parr JR, Oliveira G, Nurnberger JI, Monaco AP, Maestrini E, Klauck SM, Hakonarson H, Haines JL, Geschwind DH, Freitag CM, Folstein SE, Ennis S, Coon H, Battaglia A, Szatmari P, Sutcliffe JS, Hallmayer J, Gill M, Cook EH, Buxbaum JD, Devlin B, Gallagher L, Betancur C, Scherer SW. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">94</span>:677–94.</span> [<a href="/pmc/articles/PMC4067558/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4067558</span></a>] [<a href="/pubmed/24768552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24768552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.rauch.2012.1674">Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Ropke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schrock E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. <span><span class="ref-journal">Lancet. </span>2012;<span class="ref-vol">380</span>:1674–82.</span> [<a href="/pubmed/23020937" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23020937</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.shen.2015.1794">Shen T, Ji F, Yuan Z, Jiao J. CHD2 is required for embryonic neurogenesis in the developing cerebral cortex. <span><span class="ref-journal">Stem Cells. </span>2015;<span class="ref-vol">33</span>:1794–806.</span> [<a href="/pubmed/25786798" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25786798</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.suls.2013.967">Suls A, Jaehn JA, Kecskes A, Weber Y, Weckhuysen S, Craiu DC, Siekierska A, Djemie T, Afrikanova T, Gormley P, von Spiczak S, Kluger G, Iliescu CM, Talvik T, Talvik I, Meral C, Caglayan HS, Giraldez BG, Serratosa J, Lemke JR, Hoffman-Zacharska D, Szczepanik E, Barisic N, Komarek V, Hjalgrim H, Moller RS, Linnankivi T, Dimova P, Striano P, Zara F, Marini C, Guerrini R, Depienne C, Baulac S, Kuhlenbaumer G, Crawford AD, Lehesjoki AE, de Witte PA, Palotie A, Lerche H, Esguerra CV, De Jonghe P, Helbig I. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">93</span>:967–75.</span> [<a href="/pmc/articles/PMC3824114/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3824114</span></a>] [<a href="/pubmed/24207121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24207121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.thomas.2015.951">Thomas RH, Zhang LM, Carvill GL, Archer JS, Heavin SB, Mandelstam SA, Craiu D, Berkovic SF, Gill DS, Mefford HC, Scheffer IE. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:951–8.</span> [<a href="/pmc/articles/PMC4351660/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4351660</span></a>] [<a href="/pubmed/25672921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25672921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chd2-dis.REF.trivisano.2015.53">Trivisano M, Striano P, Sartorelli J, Giordano L, Traverso M, Accorsi P, Cappelletti S, Claps DJ, Vigevano F, Zara F, Specchio N. CHD2 mutations are a rare cause of generalized epilepsy with myoclonic-atonic seizures. <span><span class="ref-journal">Epilepsy Behav. </span>2015;<span class="ref-vol">51</span>:53–6.</span> [<a href="/pubmed/26262932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26262932</span></a>]</div></li></ul></div></div><div id="chd2-dis.Chapter_Notes"><h2 id="_chd2-dis_Chapter_Notes_">Chapter Notes</h2><div id="chd2-dis.Author_Notes"><h3>Author Notes</h3><p>The Epilepsiome: A knowledgebase for genes related to human epilepsies:<br /><a href="http://epilepsygenetics.net/2015/10/26/chd2-this-is-what-you-need-to-know-in-2015/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHD2 &#x02013; this is what you need to know in 2015</a></p><p><a href="http://www.washington.edu/medicine/pediatrics/meflab/about" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mefford Laboratory</a><br />University of Washington<br />Department of Pediatrics<br />HSB RR309<br />1959 NE Pacific Street<br />Seattle, WA 98195<br />Phone: +1 206.543.4748</p></div><div id="chd2-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>10 December 2015 (bp) Review posted live</div></li><li class="half_rhythm"><div>14 May 2015 (hm/gc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK333201</span><span class="label">PMID: <a href="/pubmed/26677509" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26677509</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/chchd10-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cd-chst3/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK333201&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK333201/?report=reader">PubReader</a></li><li><a href="/books/NBK333201/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK333201" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK333201" style="display:none" title="Cite this Page"><div class="bk_tt">Carvill G, Helbig I, Mefford H. CHD2-Related Neurodevelopmental Disorders. 2015 Dec 10. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK333201/pdf/Bookshelf_NBK333201.pdf">PDF version of this page</a> (498K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#chd2-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#chd2-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#chd2-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#chd2-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#chd2-dis.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#chd2-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#chd2-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#chd2-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#chd2-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#chd2-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#chd2-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#chd2-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1106[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHD2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4183248" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4183248" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4183248" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4183248" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27905812" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">STXBP1</i> Encephalopathy with Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">STXBP1</i> Encephalopathy with Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Khaikin Y, Mercimek-Mahmutoglu S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28211668" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Propeller Protein-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Propeller Protein-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Haack T, Hayflick SJ, Hogarth P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301494" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miller IO, Sotero de Menezes MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24851285" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNQ3</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNQ3</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miceli F, Soldovieri MV, Joshi N, Weckhuysen S, Cooper EC, Taglialatela M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27559564" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN8A</i>-Related Epilepsy with Encephalopathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN8A</i>-Related Epilepsy with Encephalopathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hammer MF, Wagnon JL, Mefford HC, Meisler MH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26677509" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26677509" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc944239a66ee2ba3ef4c6">CHD2-Related Neurodevelopmental Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">CHD2-Related Neurodevelopmental Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:28:35-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BD960DFC8D3F100000000038101C2&amp;ncbi_session=CE8BD960DFC94421_0897SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK333201%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK333201&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK333201/&amp;ncbi_pagename=CHD2-Related Neurodevelopmental Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BD960DFC94421_0897SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>